Protease-activated receptors in health and disease
Physiological Reviews · 01.01.2023 · 103 (1) · 717-785
DOI: 10.1152/physrev.00044.2021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Reviews, erschienen am 01.01.2023. Verfasst von Chloe J Peach und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathobiology, College of Dentistry, New York University, New York, New York. Hauptthemen laut MEDLINE: Receptors, Proteinase-Activated, Signal Transduction. Die Arbeit wurde bisher 127-mal zitiert (Crossref) und nennt 630 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NIDDK NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Proteases are signaling molecules that specifically control cellular functions by cleaving protease-activated receptors (PARs). The four known PARs are members of the large family of G protein-coupled receptors. These transmembrane receptors control most physiological and pathological processes and are the target of a large proportion of therapeutic drugs. Signaling proteases include enzymes from the circulation; from immune, inflammatory epithelial, and cancer cells; as well as from commensal and pathogenic bacteria. Advances in our understanding of the structure and function of PARs provide insights into how diverse proteases activate these receptors to regulate physiological and pathological processes in most tissues and organ systems. The realization that proteases and PARs are key mediators of disease, coupled with advances in understanding the atomic level structure of PARs and their mechanisms of signaling in subcellular microdomains, has spurred the development of antagonists, some of which have advanced to the clinic. Herein we review the discovery, structure, and function of this receptor system, highlight the contribution of PARs to homeostatic control, and discuss the potential of PAR antagonists for the treatment of major diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathobiology, College of Dentistry, New York University, New York, New York.
- Department of Neuroscience and Physiology and Neuroscience Institute, Grossman School of Medicine, New York University, New York, New York.
- Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
- Bluestone Center for Clinical Research, Department of Oral and Maxillofacial Surgery, New York University College of Dentistry, New York, New York.
ORCID-Profile: Laura E Edgington-Mitchell, Nigel W Bunnett
Förderung
- NIDCR NIH HHS
- NIDDK NIH HHS
- NINDS NIH HHS
- Australian Research Council
- DOD | Defense Advanced Research Projects Agency
- HHS | NIH | National Institute of Dental and Craniofacial Research
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- HHS | NIH | National Institute of Neurological Disorders and Stroke
Zitieren
APA
Peach, C. J., Edgington-Mitchell, L. E., Bunnett, N. W., & Schmidt, B. L. (2023). Protease-activated receptors in health and disease. Physiological Reviews, 103(1), 717-785. https://doi.org/10.1152/physrev.00044.2021
Vancouver
Peach CJ, Edgington-Mitchell LE, Bunnett NW, Schmidt BL. Protease-activated receptors in health and disease. Physiological Reviews. 2023;103(1):717-785. doi:10.1152/physrev.00044.2021
BibTeX
@article{Peach2023,
author = {Peach, Chloe J and Edgington-Mitchell, Laura E and Bunnett, Nigel W and Schmidt, Brian L},
title = {Protease-activated receptors in health and disease},
journal = {Physiological Reviews},
year = {2023},
volume = {103},
number = {1},
pages = {717--785},
doi = {10.1152/physrev.00044.2021}
}
EUVIMED